Total Payments
$16,081
2024 Payments
$428.25
Companies
38
Transactions
517
Medicare Patients
1,727
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$9,125 (56.7%)
Consulting$3,025 (18.8%)
Other$2,250 (14.0%)
Travel$1,672 (10.4%)
Education$9.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,125 | 499 | 56.7% |
| Consulting Fee | $3,025 | 3 | 18.8% |
| Honoraria | $2,250 | 1 | 14.0% |
| Travel and Lodging | $1,672 | 13 | 10.4% |
| Education | $9.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cardinal Health 108, LLC | $4,832 | 22 | $0 (2018) |
| Horizon Therapeutics plc | $2,711 | 22 | $0 (2023) |
| ABBVIE INC. | $1,010 | 73 | $0 (2024) |
| Lilly USA, LLC | $849.75 | 45 | $0 (2022) |
| Amgen Inc. | $826.35 | 39 | $0 (2024) |
| UCB, Inc. | $768.00 | 37 | $0 (2024) |
| Janssen Biotech, Inc. | $724.00 | 28 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $667.92 | 39 | $0 (2023) |
| Celgene Corporation | $519.02 | 30 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $471.31 | 25 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $428.25 | 18 | UCB, Inc. ($185.34) |
| 2023 | $719.72 | 31 | Janssen Biotech, Inc. ($180.88) |
| 2022 | $298.28 | 11 | Lilly USA, LLC ($86.93) |
| 2021 | $508.70 | 21 | AbbVie Inc. ($106.24) |
| 2020 | $358.96 | 18 | Horizon Therapeutics plc ($66.78) |
| 2019 | $4,308 | 110 | Horizon Therapeutics plc ($2,534) |
| 2018 | $4,984 | 175 | Cardinal Health 108, LLC ($2,358) |
| 2017 | $4,474 | 133 | Cardinal Health 108, LLC ($2,474) |
All Payment Transactions
517 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $33.49 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Bone Health | ||||||
| 09/25/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: Immunology | ||||||
| 09/25/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Dermatology | ||||||
| 08/21/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: Immunology | ||||||
| 08/01/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 07/24/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: Immunology | ||||||
| 06/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Immunology | ||||||
| 01/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $26.78 | General |
| 12/13/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2023 | AbbVie Inc. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Immunology | ||||||
| 11/15/2023 | AbbVie Inc. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2023 | AbbVie Inc. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 297 | 32,081 | $425,339 | $194,455 |
| 2022 | 12 | 374 | 52,172 | $629,357 | $315,474 |
| 2021 | 14 | 545 | 83,235 | $1.3M | $792,077 |
| 2020 | 13 | 511 | 45,154 | $526,468 | $361,163 |
Total Patients
1,727
Total Services
212,642
Medicare Billing
$1.7M
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 13 | 30,000 | $262,500 | $117,504 | 44.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 18 | 1,380 | $35,880 | $25,241 | 70.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 250 | $50,000 | $22,529 | 45.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 19 | 100 | $40,000 | $11,144 | 27.9% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 30 | 174 | $22,968 | $10,884 | 47.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 29 | $6,960 | $3,672 | 52.8% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 14 | 26 | $4,200 | $2,300 | 54.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $2,550 | $1,094 | 42.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 105 | $281.40 | $87.56 | 31.1% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 18 | 49,600 | $434,000 | $215,938 | 49.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 22 | 1,680 | $43,680 | $29,016 | 66.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 273 | $54,600 | $27,940 | 51.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 39 | 285 | $37,620 | $19,107 | 50.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 16 | 97 | $38,800 | $11,724 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $5,500 | $3,143 | 57.1% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 14 | 33 | $4,950 | $2,773 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 34 | $5,100 | $2,588 | 50.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $3,360 | $2,155 | 64.1% |
| 76882 | Limited ultrasound scan of joint or other extremity structure lacking blood vessels | Office | 2022 | 12 | 13 | $975.00 | $637.59 | 65.4% |
| 82306 | Vitamin d-3 level | Office | 2022 | 12 | 12 | $480.00 | $351.02 | 73.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 21 | 109 | $292.12 | $101.80 | 34.8% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 23 | 74,400 | $651,000 | $429,436 | 66.0% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 13 | 5,453 | $319,001 | $217,148 | 68.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 180 | 360 | $66,675 | $35,466 | 53.2% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 48 | 469 | $61,908 | $33,882 | 54.7% |
About Dr. Heidi Sami, M.D
Dr. Heidi Sami, M.D is a Specialist healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1720305857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heidi Sami, M.D has received a total of $16,081 in payments from pharmaceutical and medical device companies, with $428.25 received in 2024. These payments were reported across 517 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($9,125).
As a Medicare-enrolled provider, Sami has provided services to 1,727 Medicare beneficiaries, totaling 212,642 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Annapolis, MD
- Active Since 04/29/2010
- Last Updated 09/01/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720305857
Products in Payments
- KRYSTEXXA (Biological) $2,553
- Cimzia (Drug) $702.96
- ORENCIA (Biological) $667.92
- Humira (Biological) $596.60
- ACTHAR (Biological) $471.31
- Enbrel (Biological) $459.23
- TALTZ (Drug) $408.30
- KEVZARA SARILUMAB INJECTION (Biological) $398.17
- SIMPONI ARIA (Biological) $299.83
- TREMFYA (Drug) $287.25
- RAYOS (Drug) $232.52
- XELJANZ (Drug) $219.60
- PENNSAID (Drug) $218.32
- RINVOQ (Biological) $193.22
- EVENITY (Biological) $175.43
- Tymlos (Biological) $165.84
- COSENTYX (Biological) $147.34
- REMICADE (Biological) $125.00
- Rasuvo (Drug) $103.45
- COSENTYX (Drug) $92.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Annapolis
Dr. Jeffrey Mckeeby, M.d, M.D
Specialist — Payments: $43,218
Specialist $43,218
Dr. Gilbert Mottla, M.d, M.D
Specialist — Payments: $37,780
Specialist $37,780
Mara Holton, Md, MD
Specialist — Payments: $10,056
Specialist $10,056
Dr. Stephen Stanziale, M.d, M.D
Specialist — Payments: $8,496
Specialist $8,496
Dr. Eric Schwartz, M.d, M.D
Specialist — Payments: $5,029
Specialist $5,029
Dr. Marcus Penn, M.d, M.D
Specialist — Payments: $4,412
Specialist $4,412